| Primary |
| Anxiety |
33.6% |
| Depression |
19.7% |
| Bipolar I Disorder |
4.5% |
| Insomnia |
4.5% |
| Generalised Anxiety Disorder |
4.1% |
| Major Depression |
4.1% |
| Pain |
4.1% |
| Myocardial Ischaemia |
3.3% |
| Mental Disorder |
2.9% |
| Obsessive-compulsive Disorder |
2.9% |
| Emotional Disorder |
2.5% |
| Affective Disorder |
2.0% |
| Hypertension |
2.0% |
| Anxiety Disorder |
1.6% |
| Asthma |
1.6% |
| Breast Cancer |
1.6% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hallucination, Visual |
1.2% |
| Headache |
1.2% |
| Psychomotor Hyperactivity |
1.2% |
|
| Drug Ineffective |
12.3% |
| Suicide Attempt |
9.6% |
| Death |
7.5% |
| Pregnancy |
7.5% |
| Tinnitus |
6.8% |
| Tremor |
6.2% |
| Insomnia |
4.8% |
| Vision Blurred |
4.8% |
| Drug Screen False Positive |
4.1% |
| Palpitations |
4.1% |
| Weight Increased |
4.1% |
| Choking |
3.4% |
| Nausea |
3.4% |
| Somnolence |
3.4% |
| Suicidal Ideation |
3.4% |
| Weight Decreased |
3.4% |
| Alopecia |
2.7% |
| Anxiety |
2.7% |
| Dizziness |
2.7% |
| Drug Screen Positive |
2.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.6% |
| Depression |
20.3% |
| Product Used For Unknown Indication |
19.9% |
| Anxiety |
8.1% |
| Myocardial Ischaemia |
3.4% |
| Hypertension |
3.3% |
| Pain |
3.0% |
| Smoking Cessation Therapy |
2.7% |
| Headache |
2.2% |
| Ill-defined Disorder |
2.2% |
| Intentional Overdose |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hepatitis C |
1.7% |
| Anxiety Disorder |
1.6% |
| Drug Exposure During Pregnancy |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Mental Disorder |
1.3% |
| Bipolar Disorder |
1.2% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Drug Hypersensitivity |
15.4% |
| Suicide Attempt |
8.8% |
| Vomiting |
7.4% |
| Weight Decreased |
6.6% |
| Hypothyroidism |
5.9% |
| Drug Ineffective |
5.1% |
| Urinary Tract Infection |
5.1% |
| Vision Blurred |
5.1% |
| Hypoglycaemia |
4.4% |
| Sleep Disorder |
4.4% |
| Suicidal Ideation |
4.4% |
| Tinnitus |
4.4% |
| Tremor |
3.7% |
| Ventricular Septal Defect |
3.7% |
| Anxiety |
2.9% |
| Depression |
2.9% |
| Overdose |
2.9% |
| Convulsion |
2.2% |
| Grand Mal Convulsion |
2.2% |
| Incorrect Dose Administered |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.1% |
| Depression |
15.6% |
| Anxiety |
13.7% |
| Drug Use For Unknown Indication |
8.7% |
| Pain |
5.6% |
| Bipolar Disorder |
5.1% |
| Hypertension |
4.5% |
| Insomnia |
3.6% |
| Sleep Disorder |
2.7% |
| Smoking Cessation Therapy |
2.1% |
| Schizophrenia |
2.0% |
| Multiple Sclerosis |
1.9% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Osteoporosis |
1.7% |
| Asthma |
1.6% |
| Affective Disorder |
1.6% |
| Crohn's Disease |
1.5% |
| Hepatitis C |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Blood Cholesterol Increased |
1.4% |
|
| Type 2 Diabetes Mellitus |
16.5% |
| Weight Increased |
14.2% |
| Weight Decreased |
10.8% |
| Vomiting |
10.3% |
| Suicidal Ideation |
4.7% |
| Tremor |
4.3% |
| Nausea |
4.2% |
| Drug Ineffective |
4.0% |
| Vision Blurred |
3.8% |
| Pain |
3.2% |
| Suicide Attempt |
2.9% |
| Myocardial Infarction |
2.8% |
| Pancreatitis |
2.6% |
| Pulmonary Embolism |
2.4% |
| Headache |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
| Urinary Tract Infection |
2.2% |
| Depression |
2.2% |
| Insomnia |
2.2% |
| Pneumonia |
2.2% |
|
| Interacting |
| Anxiety |
12.4% |
| Smoking Cessation Therapy |
11.0% |
| Product Used For Unknown Indication |
9.0% |
| Muscle Spasms |
8.3% |
| Depression |
6.9% |
| Muscle Relaxant Therapy |
6.9% |
| Abdominal Discomfort |
6.2% |
| Hypersensitivity |
5.5% |
| Pain |
4.8% |
| Attention Deficit/hyperactivity Disorder |
3.4% |
| Migraine |
3.4% |
| Neuralgia |
3.4% |
| Obsessive-compulsive Disorder |
3.4% |
| Sleep Disorder |
3.4% |
| Amyotrophic Lateral Sclerosis |
2.1% |
| Bipolar Disorder |
2.1% |
| Emotional Disorder |
2.1% |
| Headache |
2.1% |
| Mental Disorder |
2.1% |
| Blood Pressure |
1.4% |
|
| Tobacco Withdrawal Symptoms |
22.2% |
| Hypothyroidism |
11.1% |
| Nausea |
7.4% |
| Somnolence |
7.4% |
| Violence-related Symptom |
7.4% |
| Weight Decreased |
7.4% |
| Drug Interaction |
3.7% |
| Fear |
3.7% |
| Hypothermia |
3.7% |
| Irritability |
3.7% |
| Nightmare |
3.7% |
| Respiratory Arrest |
3.7% |
| Sedation |
3.7% |
| Sluggishness |
3.7% |
| Speech Disorder |
3.7% |
| Tremor |
3.7% |
|
